Emily Chiu

Anti-NKG2C/IL-15/anti-CD33 Killer Engager Directs Primary and iPSC-derived NKG2C+ NK cells to Specifically Target Myeloid Leukemia.

Jeffrey S. Miller, K. Malmberg, D. Vallera, 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma

Justin H Hwang, Cheng-Ying Wu, N. Snyder, 2023, Science Translational Medicine.